Please login to the form below

Not currently logged in
Email:
Password:

Samsung

This page shows the latest Samsung news and features for those working in and with pharma, biotech and healthcare.

Apple Watch shows promise in heart study, but doctors sceptical

Apple Watch shows promise in heart study, but doctors sceptical

The tech giant is still ahead of its rivals Samsung and Alphabet when it comes to introducing new health features to its products, but has a long way to go to

Latest news

  • Pfizer closes on EU approval of lung cancer drug Vizimpro Pfizer closes on EU approval of lung cancer drug Vizimpro

    The two new biosimilars will join products from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit in an assault on AbbVie’s market share for the

  • Hardy returns to Genentech as CEO Hardy returns to Genentech as CEO

    In the US, the FDA has already approved three Herceptin copycats – Celltrion and Teva’s Herzuma, Samsung Bioepis’ Ontruzant and Myland’s Ogivri, however the companies will have to wait until

  • Generic Differentiation Generic Differentiation

    And evolution predicts a fourth model, the ‘Frugal Followers’, that is not yet fully emerged but Samsung Bioepis looks like a contender to make very low-cost biosimilars.

  • NHS says Humira biosimilar deal will save £300m NHS says Humira biosimilar deal will save £300m

    end. Amgen’s copy Amgevita and Samsung and Biogen’s Imraldi both gained full EU approval last year, and have been joined since by Hyrimoz from Novartis’ Sandoz division, Boehringer

  • First Humira biosimilars reach EU market First Humira biosimilars reach EU market

    Copycat versions of the TNF inhibitor  from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit are starting to become available in their first EU markets now that ... Also already launched is Samsung Bioepis and

More from news
Approximately 27 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The deal between Merck &Co and Samsung Bioepis has been in place since 2013, when Merck &Co began to work with Samsung Bioepis to produce biosimilars. ... Merck &Co has paid $155m to Samsung Bioepis to cover the investments made so far, plus interest, in

  • The three forces behind the re-imagining of patient care The three forces behind the re-imagining of patient care

    Pharma will need to embrace the extremes of disruption from large technology companies such as Apple, Samsung  and IBM to a small tech start-up, such as the one in Uganda

  • Deal Watch October 2016 Deal Watch October 2016

    For example Samsung Bioepis also based in South Korea, signed a deal with Merck &Co in 2013 for a range of biosimilars including infliximab, trastuzumab and etanercept (Amgen's Enbrel with

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    as those from FitBit, Samsung and Nike – being launched over the past three years. ... This all rides on the success, or otherwise, of firms like Apple and Samsung in getting as many people as possible involved in its big data projects.

  • From measurement to management From measurement to management

    Apple, Samsung, Google and other key players are open and welcoming to pharma companies that want to genuinely partner and move forward together.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

  • Philips names head of healthcare for South Asia Philips names head of healthcare for South Asia

    Garde, who most recently lead enterprise business at Samsung, will be responsible for driving and building the healthcare business for Philips in India. ... Garde was only with Samsung for a short period, joining in July 2013.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Battle of the Voice Assistants and Voice Search

    At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung. ... The voice assistant battle is hotting up between the major players; Amazon, Google, Apple, Microsoft and Samsung as

  • An agency called Owen

    At-a-glance crib sheet on how the battle of the voice assistants is shaping up between Amazon, Google, Apple, Microsoft and Samsung.

  • Back from the future – innovation for pharma

    From individual sets on start-up booths, to the full-on VR experience of the Samsung Lounge, immersive experiences were the order of the day. ... Samsung focused on giving you realistic experiences, a rollercoaster ride where the Gear VR headset is

  • CES 2016 report: new technologies that could improve patient care, by Andy Hastie

    Paired with a smartphone app, Samsung’s wellness belt, or “Welt”, monitors your waistline and counts your steps throughout the day.

  • Evolution of the wearable tech revolution

    Considering that the majority of these fall within the health segment, and that tech giants Apple, Google, Microsoft and Samsung are actively moving into this arena, these numbers certainly seem to ... adoption. To specifically overcome this problem, and

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics